Ledger.Open graph →
SEC Form D · filed August 4, 2015

Principia Biopharma Inc

Offering
$15.3M
Sold
$15.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Martin Babler · SOUTH SAN FRANCISCO, CAExec · DirectorPeter Thompson · New York, NYDirectorSrinivas Akkaraju · SOUTH SAN FRANCISCO, CADirectorMichael Dybbs · SOUTH SAN FRANCISCO, CADirectorSimeon George · Menlo Park, CADirectorNassim Usman · Boulder, CODirectorR. S. Doyle · Wexford, PAExec · DirectorMichael S. Dignazio · Wexford, PADirectorWilliam P. Malloy · Wexford, PADirectorJill F. Schiaparelli · Wexford, PADirectorMary Del Brady · Wexford, PADirectorLewis J. Shuster · SOUTH SAN FRANCISCO, CADirectorJan Berkow · Wexford, PAExec · DirectorChang Hoon Choi · Jung-gu, Seoul, M5DirectorJohn Hathaway · Pittsburgh, PADirectorDavid Rodriguez-Fraile · New York, NYDirectorGreg Elmlinger · San Francisco, CADirectorLewis J. Shuster · SOUTH SAN FRANCISCO, CADirectorMichael Dybbs · SOUTH SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗